ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,20
-0,77%
Dow Jones
38 834,86
0,15%
DAX
18 067,91
-0,31%
Brent Oil
84,55
-0,17%
Bitcoin
65 115,31
0,23%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. I MAB (IMAB)

  7. I MAB (IMAB) Actualités

IMAB I MAB

1,77
-0,05 (-2,75%)
19 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
I MAB IMAB NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,05 -2,75% 1,77 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,80 1,76 1,81 1,77 1,82
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/6/202413:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/6/202413:00PRNUSI-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical..
05/6/202413:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/6/202413:00PRNUSI-Mab Announces Collaboration with Bristol Myers Squibb to..
30/5/202423:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/5/202423:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/5/202423:05GLOBEI-Mab Announces Encouraging Phase 1 Clinical Data of..
22/5/202413:00PRNUSI-Mab to Participate at the Jefferies Global Healthcare..
30/4/202413:00PRNUSI-MAB Filed 2023 Annual Report on Form 20-F
05/4/202413:00PRNUSI-Mab to Participate at the 23rd Annual Needham Virtual..
02/4/202422:01PRNUSI-Mab Announces Closing of the Divestiture of Business..
14/3/202422:00PRNUSI-Mab Reports Full Year 2023 Financial Results and Business..
09/2/202422:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202412:07EDGAR2Form 144 - Report of proposed sale of securities
07/2/202412:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/2/202412:00PRNUSI-Mab Signs Agreement to Divest its Assets and Business..
07/2/202402:55EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
06/2/202412:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202412:21EDGAR2Form 144 - Report of proposed sale of securities
02/1/202423:08DJNADRs Slump; FLJ Group Declines 21%
29/12/202312:12EDGAR2Form 144 - Report of proposed sale of securities
26/12/202312:22EDGAR2Form 144 - Report of proposed sale of securities
01/12/202320:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
16/11/202312:43EDGAR2Form 144 - Report of proposed sale of securities
06/11/202314:00PRNUSI-Mab Announces Participation at Jefferies and Piper..
02/11/202313:00PRNUSFelzartamab Granted Breakthrough Therapy Designation by U.S...
01/11/202313:00PRNUSI-Mab Announces Poster Presentations of 4-1BB Bispecific..
16/10/202314:00PRNUSI-Mab Announces Phase 1 Data of Givastomig at ESMO 2023
10/10/202317:04EDGAR2Form 144 - Report of proposed sale of securities
10/10/202314:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202314:00PRNUSI-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1BB..
29/9/202312:15EDGAR2Form 144 - Report of proposed sale of securities
22/9/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202314:00PRNUSI-Mab Announces Upcoming Participation at September..
17/8/202312:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202312:00PRNUSI-Mab Provides Mid-Year 2023 Financial Results, Business and..
08/8/202314:00PRNUSI-Mab to Report Mid-Year 2023 Financial Results, Business..
11/7/202312:17EDGAR2Form 144 - Report of proposed sale of securities
05/7/202314:39EDGAR2Form 144 - Report of proposed sale of securities
05/7/202314:34EDGAR2Form 144 - Report of proposed sale of securities
05/7/202314:22EDGAR2Form 144 - Report of proposed sale of securities
05/7/202314:00PRNUSI-Mab Announces Publication of Claudin18.2 x 4-1BB..
22/6/202314:00PRNUSI-Mab Announces the Appointment of Raj Kannan as CEO

Dernières Valeurs Consultées

NASDAQ
IMAB
I MAB
ASX
DSX
BIT
P1CN86
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés